Sustained Virological Response After 4 Weeks of Telaprevir, Peginterferon, and Ribavirin in an Asian Patient with Genotype 1 Chronic Hepatitis C and IL28B Genotype CC

By Brulotte Natalie   Hahn Hejin   Lee Maximilian  

Digestive Diseases and Sciences, Vol. 59, Iss. 4, 2014-04 ,pp. : 737-739

Springer Publishing Company

Access to resources Recommend Favorite

Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b

By  

Case Reports in Gastroenterology, Vol. 10, Iss. 2, 2016-08 ,pp. : 417-422

Karger

Access to resources Recommend Favorite

Pegylated Interferon plus Ribavirin Combination Therapy for Chronic Hepatitis C with High Viral Load of Serum Hepatitis C Virus RNA, Genotype 1b, Discontinued on Attaining Sustained Virological Response at Week 16 after Onset of Acute Pancreatitis

By  

Digestion, Vol. 79, Iss. 1, 2009-02 ,pp. : 36-39

Karger

Access to resources Recommend Favorite

Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection

By  

Current HIV Research, Vol. 7, Iss. 4, 2009-07 ,pp. : 447-455

Bentham Science Publishers

Access to resources Recommend Favorite

Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study

By Nishiguchi Shuhei   Enomoto Hirayuki   Aizawa Nobuhiro   Nishikawa Hiroki   Osaki Yukio   Tsuda Yasuhiro   Higuchi Kazuhide   Okazaki Kazuichi   Seki Toshihito   Kim Soo   Hongo Yasushi   Jyomura Hisato   Nishida Naoshi   Kudo Masatoshi  

Journal of Gastroenterology, Vol. 49, Iss. 3, 2014-03 ,pp. : 492-501

Springer Publishing Company

Access to resources Recommend Favorite